Date: Thursday, September 15, 2022

Time: 3:00pm - 6:30pm

Location: Allogene Therapeutics | 7382 Gateway Blvd. | Newark CA 94560

Event Description

During the event we will start with simultaneous facility tours and networking with appetizers and drinks. Then we will transition into a panel discussion where we will discuss our expert panel will discussion the sustainable features of the facility.

Agenda

3:00-4:30pm | Networking & Tours

4:30-5:30pm | Panel

5:30-6:30pm | Networking

Panelists

• Ben Beneski Vice President, Manufacturing Site Head at Allogene Therapeutics

• Charles Doan, Sr. Director EHS & Security at Allogene Therapeutics

• George Scott, Senior Director Facilities and Engineering at Allogene Therapeutics, Cell Forge One

• Tyler Tsang, Senior Director of Quality Control at Allogene Therapeutics

• Jeff Wegner Energy + Sustainability SME, Associate at CRB

The event is limited to 50 people. CLICK HERE TO REGISTER TODAY AND RESERVE YOUR SPOT.

More About Allogene Therapeutics

Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.

ALL ATTENDEES ARE REQUIRED TO AGREE TO ALL THE TERMS OF THE ALLOEGENE THERAPEUTICS NDA. CLICK HERE TO REVIEW NDA AGREEMENT: https://www.i2slnorcal.org/events/allogene-therapeutics-nda-agreement